Literature DB >> 6093367

Characterisation of a herpes simplex virus type 1 mutant which has a temperature-sensitive defect in penetration of cells and assembly of capsids.

C Addison, F J Rixon, J W Palfreyman, M O'Hara, V G Preston.   

Abstract

A herpes simplex virus type 1 (HSV-1) mutant, ts1204, which has a temperature-sensitive (ts) mutation located within genome map coordinates 0.318 to 0.324, close to but outside the coding sequences of the glycoprotein gB gene, has been characterised. Although this mutant adsorbed to the cell surface at the nonpermissive temperature (NPT), it failed to penetrate the cell membrane. As a consequence of this defect, high multiplicities of infection of ts1204 blocked subsequent infection of cells by wild-type HSV-1. By contrast, at the NPT, superinfection of cells with HSV-2 was not inhibited by prior infection with ts1204. The penetration defect could be overcome either by brief incubation of mutant virus-infected cells at the permissive temperature, or by treatment of the cells with polyethylene glycol, a compound which promotes fusion of membranes. Upon continued incubation of ts1204-infected cells at the NPT, low numbers of capsids were assembled. Although these capsids all had some internal structure, they did not contain DNA. Another mutant, ts1208, which lies in the same complementation group as ts1204, penetrated cells normally at the NPT, but like ts1204, had a defect in the formation of functional capsids. Evidence presented in this paper suggests that the gene in which the ts1204 and ts1208 lesions map encodes a structural polypeptide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093367     DOI: 10.1016/0042-6822(84)90349-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  56 in total

1.  Packaging-competent capsids of a herpes simplex virus temperature-sensitive mutant have properties similar to those of in vitro-assembled procapsids.

Authors:  F J Rixon; D McNab
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  DNA cleavage and packaging proteins encoded by genes U(L)28, U(L)15, and U(L)33 of herpes simplex virus type 1 form a complex in infected cells.

Authors:  Philippa M Beard; Naomi S Taus; Joel D Baines
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Herpes simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3' processing.

Authors:  J McLauchlan; A Phelan; C Loney; R M Sandri-Goldin; J B Clements
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

Review 4.  Herpesvirus transport to the nervous system and back again.

Authors:  Gregory Smith
Journal:  Annu Rev Microbiol       Date:  2012-06-15       Impact factor: 15.500

5.  The UL25 protein of pseudorabies virus associates with capsids and localizes to the nucleus and to microtubules.

Authors:  K Kaelin; S Dezélée; M J Masse; F Bras; A Flamand
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor.

Authors:  N Langeland; H Holmsen; J R Lillehaug; L Haarr
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

7.  The capsid and tegument of the alphaherpesviruses are linked by an interaction between the UL25 and VP1/2 proteins.

Authors:  Kelly Elizabeth Coller; Joy I-Hsuan Lee; Aki Ueda; Gregory Allan Smith
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

8.  Packaging of genomic and amplicon DNA by the herpes simplex virus type 1 UL25-null mutant KUL25NS.

Authors:  N D Stow
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Herpes simplex virus type 1 recombination: the Uc-DR1 region is required for high-level a-sequence-mediated recombination.

Authors:  R E Dutch; B V Zemelman; I R Lehman
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  UL27.5 is a novel gamma2 gene antisense to the herpes simplex virus 1 gene encoding glycoprotein B.

Authors:  Y E Chang; L Menotti; F Filatov; G Campadelli-Fiume; B Roizman
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.